Welcome to our dedicated page for 3M SEC filings (Ticker: MMM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
3M Company filings document operating results, guidance, governance, capital structure, and material corporate events for the company's diversified industrial and consumer portfolio. Form 8-K reports include quarterly earnings releases, financial-condition updates, board changes, and material agreements such as credit facilities and related guarantees.
Proxy filings describe director elections, board committee structure, executive compensation, shareholder voting matters, and governance policies. The filing record also identifies 3M's common stock and listed notes, alongside disclosures involving litigation-related adjustments, manufactured PFAS products, Solventum ownership effects, transformation costs, and other items affecting reported results and risk presentation.
3M senior vice president and chief accounting officer Theresa E. Reinseth reported routine equity compensation activity. On February 6, 2026, 2,655 restricted stock units vested and were converted into 2,655 shares of 3M common stock at an exercise price of $0.
On the same date, 2,655 common shares were acquired at a transaction price of $172.65 per share, and 858 shares were withheld (code "F") at $172.65 per share, typically reflecting shares retained to cover taxes. After these transactions, she directly held about 4,380.5834 common shares and indirectly held 565 shares through a 401(k)/PAESOP trust.
3M executive Mark W. Murphy reported routine stock compensation activity. On February 6, 2026, he exercised 8,895 restricted stock units, each convertible into one share of 3M common stock, receiving the same number of shares at a price of $172.65 per share.
To cover tax obligations, 3,238 common shares were withheld at $172.65 per share, leaving Murphy with 22,871.9561 3M common shares held directly after the transactions. The restricted stock units had vested in full three years after their February 7, 2023 grant date.
3M Group President Christian T. Goralski Jr. reported equity transactions involving company stock. On February 6, 2026, 5,639 restricted stock units were converted into the same number of 3M common shares at an exercise price of $172.65 per share.
On the same date, 1,769 of those common shares were disposed of in a transaction coded “F,” reflecting shares withheld to cover tax obligations at $172.65 per share. After these transactions, Goralski directly owned 6,845.8033 shares of 3M common stock, and the reported restricted stock units balance was reduced to zero.
3M executive Zoe L. Dickson, EVP & Chief HR Officer, reported equity transactions on February 6, 2026. Dickson converted 4,764 restricted stock units into the same number of 3M common shares at an exercise price of $0, reflecting vesting of a prior equity grant.
On the same date, 1,500 common shares were disposed of at $172.65 per share in a transaction coded "F," indicating shares withheld to cover taxes in connection with the vesting. After these transactions, Dickson directly beneficially owned 21,123.4401 shares of common stock and indirectly held 299 shares through a 401k/PAESOP trust.
The filing notes that each restricted stock unit represents a contingent right to receive one share of 3M common stock and that the RSUs involved in this transaction vest 100% three years from their grant date of February 7, 2023, aligning with 3M’s deferred compensation and equity incentive arrangements.
3M Group President Beatriz Karina Chavez Rodriguez reported insider transactions dated February 6, 2026. She exercised 6,887 restricted stock units, each converting into one share of 3M common stock, and acquired the same number of common shares at $172.65 per share.
On the same date, she disposed of 2,307 common shares at $172.65 per share, coded as transaction type F. Following these transactions, she directly beneficially owned 18,839.3048 common shares, with a separate reported direct holding of 2,209.385 shares. The derivative position in these restricted stock units decreased to zero after the exercise.
3M Executive Vice President John Patrick Banovetz reported routine equity compensation activity. On February 6, 2026, 4,818 restricted stock units converted into the same number of 3M common shares at an exercise price of $0, reflecting previously granted stock-based compensation that vested three years after the February 7, 2023 grant.
On the same day, 1,362 common shares were withheld or sold at $172.65 under transaction code “F,” typically used for tax withholding on vesting. After these transactions, Banovetz directly held 42,971.1246 shares of 3M common stock, including dividend equivalents and shares from company plans.
3M is reporting a planned insider sale of common stock under Rule 144. The notice covers 1,190 common shares with an aggregate market value of 203644.82 to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 02/09/2026.
The shares were acquired over several years through the employee stock purchase plan and restricted stock vesting, including 411 shares that vested on 02/08/2025. Common shares outstanding are listed as 526700000, providing context for the relatively small size of this planned sale.
An insider of the issuer has filed a notice of intent to sell 45,574 common shares through Fidelity Brokerage Services LLC on February 9, 2026, with an aggregate market value of $7,753,518.25 and the shares listed on the NYSE.
The shares to be sold were acquired on February 9, 2026 by exercising options originally granted on February 7, 2023 and February 8, 2022 for 25,055 and 20,519 shares, respectively, paid in cash. The issuer had 526,700,000 shares outstanding. During the prior three months, the same account holder, Zoe Dickson, sold 27,455 common shares for gross proceeds of $4,661,910.00.
3M Company insider Victoria Clarke has filed a notice of proposed stock sales under Rule 144. The filing covers 4,137 shares of common stock with an aggregate market value of 701,097.80, to be sold through Fidelity Brokerage Services on or about 02/06/2026 on the NYSE.
The 4,137 shares were acquired on 01/05/2026 through restricted stock vesting from the issuer as compensation. The notice also reports a prior sale on 01/22/2026 of 1,857 common shares for gross proceeds of 294,390.77. Shares outstanding are listed as 526,700,000.